Long-term Safety of Protopic in Atopic Eczema
NCT00560378
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
789
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatitis, Atopic
Eczema, Atopic
Interventions
DRUG:
Tacrolimus ointment 0.1%
Sponsor
Astellas Pharma Inc